Voyager Therapeutics, Inc. (VYGR) — Insider Trading

Key Insights

• Gregory L. Shiferman, SVP and General Counsel of Voyager Therapeutics, Inc., has been granted a stock option to purchase 100,000 shares of the company's common stock at an exercise price of $4.02 per share.
• The stock option vests over four years, with 1/4th of the shares vesting on the one-year anniversary of the grant date and the remaining shares vesting monthly thereafter.
• This transaction suggests that Shiferman, a key insider, is being incentivized to continue his leadership and contribution to the company's long-term success.